Phase II study of the combination Cisplatin, Etoposide, 5-Fluorouracil and folinic acid in patients with advanced squamous cell carcinoma of the esophagus

M Polee; TC (Tjebbe) Kok; PD (Peter) Siersema; Hugo Tilanus; Ted Splinter; Gerrit Stoter; Ate van der Gaast

doi:10.1097/00001813-200107000-00004

Phase II study of the combination Cisplatin, Etoposide, 5-Fluorouracil and folinic acid in patients with advanced squamous cell carcinoma of the esophagus

M Polee, TC (Tjebbe) Kok, PD (Peter) Siersema, Hugo Tilanus, Ted Splinter, Gerrit Stoter, Ate van der Gaast

Research output: Contribution to journal › Article › Academic › peer-review

39 Citations (Scopus)

Original language	Undefined/Unknown
Pages (from-to)	513-517
Number of pages	5
Journal	Anti-Cancer Drugs
Volume	12
Issue number	6
DOIs	https://doi.org/10.1097/00001813-200107000-00004
Publication status	Published - 2001

Research programs

EMC MM-03-47-06-A
EMC MM-03-86-08
EMC MM-04-20-01

Access to Document

10.1097/00001813-200107000-00004

http://hdl.handle.net/1765/73898

Cite this

@article{69eda64af3c84f678d0427acc6b0eda4,

title = "Phase II study of the combination Cisplatin, Etoposide, 5-Fluorouracil and folinic acid in patients with advanced squamous cell carcinoma of the esophagus",

author = "M Polee and Kok, {TC (Tjebbe)} and Siersema, {PD (Peter)} and Hugo Tilanus and Ted Splinter and Gerrit Stoter and {van der Gaast}, Ate",

year = "2001",

doi = "10.1097/00001813-200107000-00004",

language = "Undefined/Unknown",

volume = "12",

pages = "513--517",

journal = "Anti-Cancer Drugs",

issn = "0959-4973",

publisher = "Lippincott Williams & Wilkins",

number = "6",

}

TY - JOUR

T1 - Phase II study of the combination Cisplatin, Etoposide, 5-Fluorouracil and folinic acid in patients with advanced squamous cell carcinoma of the esophagus

AU - Polee, M

AU - Kok, TC (Tjebbe)

AU - Siersema, PD (Peter)

AU - Tilanus, Hugo

AU - Splinter, Ted

AU - Stoter, Gerrit

AU - van der Gaast, Ate

PY - 2001

Y1 - 2001

U2 - 10.1097/00001813-200107000-00004

DO - 10.1097/00001813-200107000-00004

M3 - Article

SN - 0959-4973

VL - 12

SP - 513

EP - 517

JO - Anti-Cancer Drugs

JF - Anti-Cancer Drugs

IS - 6

ER -